Trial Profile
A phase II Trial neoadjuvant paclitaxel and cisplatin in patients with locally advanced head and neck cancer
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 18 Mar 2008
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 18 Mar 2008 New trial record.